$ACH SEC Filings

Filed On	Filing
19 Oct 2026	PRE 14A
09 Oct 2026	8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing; Regulation FD Disclosure RICHMOND, VA – October 9, 2026 – Accendra Health, Inc. (NYSE: ACH) (the Company) today announced that on October 6, 2026, it received a notice (the “Notice”) from the New York Stock Exchange (the “NYSE”) notifying the Company that it is ...
07 Oct 2026	SCHEDULE 13G
06 Oct 2026	Form 4: Gardner-Smith Kenneth, Director Received 283,554 shares as a grant or award
28 Sep 2026	8-K/A: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers This letter agreement (this “Agreement”) sets forth the terms and conditions of the independent contractor relationship between Edward A. Pesicka (“Pesicka”) and Accendra Health, Inc. (the “Company”).
24 Sep 2026	Form 4: Leon Jonathan A, EVP & CFO Gave up 4,265 shares to cover exercise price or tax ($3.63K)
17 Sep 2026	8-K: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Regulation FD Disclosure +1 more Accendra Health Names Kenneth Gardner-Smith as President and Chief Executive Officer to Lead the Company’s Next Chapter of Growth
11 Sep 2026	144
17 Aug 2026	8-K: Regulation FD Disclosure
10 Aug 2026	8-A12B
10 Aug 2026	8-K: Entry into a Material Definitive Agreement; Material Modification to Rights of Security Holders +2 more
10 Aug 2026	10-Q
10 Aug 2026	8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
10 Aug 2026	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
24 Jul 2026	EFFECT
15 Jul 2026	S-3
25 Jun 2026	8-K: Other Events
15 Jun 2026	8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation +1 more
29 May 2026	SD
22 May 2026	8-K: Regulation FD Disclosure

Comments